Application Nr Approved Date Route Status External Links
NDA018701 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Haloperidol Decanoate 50 And Haloperidol Decanoate 100 Are Indicated For The Treatment Of Schizophrenic Patients Who Require Prolonged Parenteral Antipsychotic Therapy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Haloperidol Decanoate

Comments